CurifyLabs
Pharmaceutical Manufacturing • 
Helsinki, Uusimaa, Finland • 21-50 Employees
Company overview
| Headquarters | Helsinki, Uusimaa, Finland |
| Phone number | +4915155291809 |
| Website | |
| NAICS | 3254 |
| Founded | 2021 |
| Employees | 21-50 |
| Socials |
Key Contact at CurifyLabs
Charles Deangelis
U.S. Sales Director
CurifyLabs Email Formats
CurifyLabs uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@curifylabs.com), used 79.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@curifylabs.com | 79.3% |
{first name}.{last name} | john.doe@curifylabs.com | 13.8% |
{first initial}.{first initial} | j.j@curifylabs.com | 6.9% |
About CurifyLabs
CurifyLabs is a Finnish healthtech company developing solutions for manufacturing personalized medicines in pharmacies and hospitals. CurifyLabs is revolutionizing the way personalized medicines are created. We provide innovative technology that enables the automation of compounding—transforming a traditionally manual, time-intensive process into a streamlined, efficient, and accurate system. The CurifyLabs' Compounding System Solution (CSS) is an automated pharmaceutical compounding platform for non-sterile dosage forms, including tablets, troches, liquids, suppositories, vagitories, ointments and capsules. It enables better treatments for patients and improved efficiency for pharmacies and hospital pharmacies. In addition to cost savings, it ensures high manufacturing standards at the point of care through in-process quality control. The CSS is a user-friendly platform consisting of: GMP manufactured excipient bases, compounding robotics, integrated quality control tools, software and a comprehensive formulation library to meet versatile compounding needs of pharmacies.. CurifyLabs’ CSS technology is currently in use for patients by customers in Europe and US. The CurifyLabs Compounding System Solution offers an easy-to-use, turnkey solution for pharmacists and hospitals, making personalized medication production faster, safer, and more accessible to patients in need. CurifyLabs was founded in 2021 by Charlotta Topelius and Niklas Sandler Topelius.
CurifyLabs revenue & valuation
| Annual revenue | $2,823,315 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $9,100,000 |
| Total funding | $9,800,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Funding Data
Explore CurifyLabs's funding history, including investment rounds, total capital raised, and key backers.
CurifyLabs Tech Stack
Discover the technologies and tools that power CurifyLabs's digital infrastructure, from frameworks to analytics platforms.
Cookie compliance
Security
CMS
JavaScript libraries
Maps
Reverse proxies
CDN
JavaScript libraries
Analytics
Miscellaneous
Security
United Kingdom
Spain
Frequently asked questions
4.8
40,000 users
